---
schema_version: "secwatch.filing_event.v1"
accession: "0001801170-25-000279"
form_type: "8-K"
ticker: "CLOV"
cik: "0001801170"
company_name: "CLOVER HEALTH INVESTMENTS, CORP. /DE"
filed_at: "2025-11-12T23:59:59+00:00"
generated_at: "2026-05-16T21:23:14.509862+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Clover Health publishes supplemental Q&A on Q3 2025 earnings; no new financial figures disclosed

## Summary
- Filed under Regulation FD on Nov 12, 2025; document contains written responses to shareholder questions.
- Q&A covers strategic direction and topics from Q3 2025 earnings call but provides no additional financial metrics.
- CEO Andrew Toy emphasizes commitment to transparency and two-way shareholder communication.
- No guidance changes, operational updates, or material non-public information included in the exhibit.

## SEC filing metadata
- accession: 0001801170-25-000279
- form_type: 8-K
- ticker: CLOV
- cik: 0001801170
- company_name: CLOVER HEALTH INVESTMENTS, CORP. /DE
- filed_at: 2025-11-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000279/0001801170-25-000279-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000279/clov-20251112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001801170-25-000279
- JSON: https://secwatch.observer/filing/0001801170-25-000279.json
- Plain text: https://secwatch.observer/filing/0001801170-25-000279.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.